Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XVII.i

Eye-catcher: Tracer-avid pleural area or areas on PET-CT

Publications

Viswanathan C, Carter BW, Shroff GS, Godoy MC, Marom EM, Truong MT

Pitfalls in oncologic imaging: complications of chemotherapy and radiotherapy in the chest.

Seminars in roentgenology 2015 Jul;50;183-91 — 2015 Jul — 183-91

Amarante MP, Younes RN, Rigo L, de Sousa Cruz MR

Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis.

Ecancermedicalscience 2014;8;452 — 2014 — 452

Kwek BH, Aquino SL, Fischman AJ

Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.

Chest 2004 Jun;125;2356-60 — 2004 Jun — 2356-60

Weiss N, Solomon SB

Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography.

Clinical nuclear medicine 2003 Oct;28;811-4 — 2003 Oct — 811-4